We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · January 03, 2021

Preclinical Efficacy and Safety of VEGF-Grab vs Aflibercept

Investigative Ophthalmology & Visual Science

 

Additional Info

Investigative Ophthalmology & Visual Science
Preclinical Efficacy and Safety of VEGF-Grab, a Novel Anti-VEGF Drug, and Its Comparison to Aflibercept
Invest. Ophthalmol. Vis. Sci 2020 Nov 02;61(13)22, HK Hong, YJ Park, DK Kim, NK Ryoo, YJ Ko, KH Park, HM Kim, SJ Woo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading